Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor
- PMID: 7531241
- DOI: 10.1016/s0022-3476(95)70557-0
Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor
Abstract
A cytogenetically normal infant with Kostmann syndrome (severe congenital granulocytopenia) was treated with granulocyte colony-stimulating factor, which resulted in a rapid improvement in his neutrophil count and a resolution of recurrent infections. After 11 months of therapy, splenomegaly developed, with thrombocytopenia, anemia, circulating nucleated erythrocytes, and acquired monosomy 7, which evolved during a period of 7 months into acute nonlymphoblastic leukemia. The use of granulocyte colony-stimulating factor in patients with congenital marrow failure disorders may induce or hasten the onset of a malignant transformation.
Comment in
-
Can treatment with recombinant granulocyte colony-stimulating factor transform neutropenia into leukemia?J Pediatr. 1995 Nov;127(5):845-6. doi: 10.1016/s0022-3476(95)70195-8. J Pediatr. 1995. PMID: 7472851 No abstract available.
-
Granulocyte colony-stimulating factor and congenital neutropenia--risk of leukemia?J Pediatr. 1996 Jul;129(1):187-8. doi: 10.1016/s0022-3476(96)70238-x. J Pediatr. 1996. PMID: 8757597 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
